![1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)]()
1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O. · European Journal of Cancer · 2015